Home / Resource Library / Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of ELM-1 studyOdronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of ELM-1 study